Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer

The prognostic value of lymph node status among breast cancer subtypes

(2015) Guo-Shiou Liao et al.   AMERICAN JOURNAL OF SURGERY

Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy

(2015) Shannon K. Swisher et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic value of the lymph node ratio for lymph-node-positive breast cancer- is it just a denominator problem?

(2015) Upali W Jayasinghe et al.   SpringerPlus

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response

(2014) Evandro de Azambuja et al.   LANCET ONCOLOGY

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

(2014) Luca Gianni et al.   LANCET ONCOLOGY

Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy

(2014) San-Gang Wu et al.   Cancer Research and Treatment

The Number of Lymph Nodes Dissected in Breast Cancer Patients Influences the Accuracy of Prognosis

(2013) Lauren E. Wiznia et al.   ANNALS OF SURGICAL ONCOLOGY

When is a Lymph Node Dissection a Lymph Node Dissection? The Number of Lymph Nodes Resected in Sentinel and Axillary Lymph Node Dissections

(2012) Windy Olaya et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

(2011) Christoph Tausch et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre study

(2011) Nakul Saxena et al.   EUROPEAN JOURNAL OF CANCER

Lymph Node Ratio: A Proposed Refinement of Current Axillary Staging in Breast Cancer Patients

(2011) Suzanne C. Schiffman et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Improved Staging in Node-Positive Breast Cancer Patients Using Lymph Node Ratio: Results in 1,788 Patients with Long-term Follow-Up

(2010) Melissa E. Danko et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Lymph Node Ratio as an Alternative to pN Staging in Node-Positive Breast Cancer

(2009) Vincent Vinh-Hung et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy

(2008) Bhumsuk Keam et al.   BREAST CANCER RESEARCH AND TREATMENT

The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer

(2008) Pauline T Truong et al.   EUROPEAN JOURNAL OF CANCER